Annual Current Assets
$235.59 M
+$31.21 M+15.27%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual total current assets is currently $235.59 million, with the most recent change of +$31.21 million (+15.27%) on 31 December 2023. During the last 3 years, it has risen by +$14.78 million (+6.69%). PRLD annual current assets is now -20.17% below its all-time high of $295.12 million, reached on 31 December 2021.PRLD Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$156.39 M
-$26.33 M-14.41%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly total current assets is currently $156.39 million, with the most recent change of -$26.33 million (-14.41%) on 30 September 2024. Over the past year, it has dropped by -$78.53 million (-33.43%). PRLD quarterly current assets is now -57.16% below its all-time high of $365.02 million, reached on 31 March 2021.PRLD Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +15.3% | -33.4% |
3 y3 years | +6.7% | -52.0% |
5 y5 years | +1410.7% | - |
PRLD Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -20.2% | +15.3% | -52.0% | at low |
5 y | 5 years | -20.2% | +1410.7% | -57.2% | +673.3% |
alltime | all time | -20.2% | +1410.7% | -57.2% | +673.3% |
Prelude Therapeutics Incorporated Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $156.39 M(-14.4%) |
June 2024 | - | $182.71 M(-11.0%) |
Mar 2024 | - | $205.37 M(-12.8%) |
Dec 2023 | $42.08 M(+161.0%) | $235.59 M(+0.3%) |
Sept 2023 | - | $234.92 M(-9.7%) |
June 2023 | - | $260.21 M(+48.5%) |
Mar 2023 | - | $175.26 M(-14.2%) |
Dec 2022 | $16.12 M | $204.38 M(-9.9%) |
Sept 2022 | - | $226.89 M(-8.7%) |
June 2022 | - | $248.62 M(-7.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $269.97 M(-8.5%) |
Dec 2021 | $9.98 M(+259.0%) | $295.12 M(-9.4%) |
Sept 2021 | - | $325.90 M(-5.4%) |
June 2021 | - | $344.57 M(-5.6%) |
Mar 2021 | - | $365.02 M(+65.3%) |
Dec 2020 | $2.78 M(+68.9%) | $220.81 M(-7.2%) |
Sept 2020 | - | $238.06 M(+675.5%) |
June 2020 | - | $30.70 M(+51.8%) |
Dec 2019 | $1.65 M(+103.1%) | $20.22 M |
Dec 2018 | $811.00 K | - |
FAQ
- What is Prelude Therapeutics Incorporated annual total current assets?
- What is the all time high annual current assets for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual current assets year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly total current assets?
- What is the all time high quarterly current assets for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly current assets year-on-year change?
What is Prelude Therapeutics Incorporated annual total current assets?
The current annual current assets of PRLD is $235.59 M
What is the all time high annual current assets for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual total current assets is $295.12 M
What is Prelude Therapeutics Incorporated annual current assets year-on-year change?
Over the past year, PRLD annual total current assets has changed by +$31.21 M (+15.27%)
What is Prelude Therapeutics Incorporated quarterly total current assets?
The current quarterly current assets of PRLD is $156.39 M
What is the all time high quarterly current assets for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly total current assets is $365.02 M
What is Prelude Therapeutics Incorporated quarterly current assets year-on-year change?
Over the past year, PRLD quarterly total current assets has changed by -$78.53 M (-33.43%)